
Tirzepatide: Understanding Two Incretin Receptors and One Clinical Trial
What dual GIP/GLP-1 receptor activity means, and how the SURMOUNT-5 trial connects molecular pharmacology with measured weight outcomes.
Best-in-market pricing with added discounts for quantity (up to 30% off).






















KPV + LAR + BPC-157 · 500mcg each × 60 caps

50mg × 60 capsules

10mg × 60 capsules

10mg × 60 capsules

500mcg × 60 capsules

500mg × 60 capsules

20mg × 60 capsules

250mcg × 100 capsules

1mg × 60 capsules

KPV + LAR + BPC-157 · 500mcg each × 60 caps

50mg × 60 capsules

10mg × 60 capsules

10mg × 60 capsules

500mcg × 60 capsules

500mg × 60 capsules

20mg × 60 capsules

250mcg × 100 capsules

1mg × 60 capsules

KPV + LAR + BPC-157 · 500mcg each × 60 caps

50mg × 60 capsules

10mg × 60 capsules

10mg × 60 capsules

500mcg × 60 capsules

500mg × 60 capsules

20mg × 60 capsules

250mcg × 100 capsules

1mg × 60 capsules
Every lot is tested by accredited EU laboratories, and the full report is published for your quality records.Every batch is tested by accredited third-party EU laboratories. We don't ask you to take our word for it. We give you the report.
Every vial is tested to confirm it contains exactly what the label says, down to the microgram.
Learn about the mechanisms, benefits, and latest findings in peptide research.

What dual GIP/GLP-1 receptor activity means, and how the SURMOUNT-5 trial connects molecular pharmacology with measured weight outcomes.

Why studies of a full-length peptide should not automatically be used to describe a shorter fragment.

A clear explanation of Epithalon, telomere biology and the gap between a laboratory finding and evidence of longer, healthier human life.
Enter your email to receive promo codes, special offers and the latest updates.
Occasional emails only. Unsubscribe anytime.